California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

NAD+ boosters can affect how certain medications like insulin, blood pressure lowering, antidepressants, and cancer ...

An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the ...

It had the potential to disrupt the market, bring down drug costs and save patients’ lives. Gov. Gavin Newsom promised a “2024 delivery” for the insulin. It still is not here, and the ...